0001438133-20-000134.txt : 20200901 0001438133-20-000134.hdr.sgml : 20200901 20200901171938 ACCESSION NUMBER: 0001438133-20-000134 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20200828 FILED AS OF DATE: 20200901 DATE AS OF CHANGE: 20200901 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Morrison Susan CENTRAL INDEX KEY: 0001582970 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-36189 FILM NUMBER: 201155113 MAIL ADDRESS: STREET 1: 11045 ROSELLE STREET CITY: SAN DIEGO STATE: CA ZIP: 92121 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: TANDEM DIABETES CARE INC CENTRAL INDEX KEY: 0001438133 STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841] IRS NUMBER: 204327508 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 11075 ROSELLE STREET CITY: San Diego STATE: CA ZIP: 92121 BUSINESS PHONE: 858-366-6900 MAIL ADDRESS: STREET 1: 11075 ROSELLE STREET CITY: San Diego STATE: CA ZIP: 92121 4 1 wf-form4_159899515925296.xml FORM 4 X0306 4 2020-08-28 0 0001438133 TANDEM DIABETES CARE INC TNDM 0001582970 Morrison Susan C/O TANDEM DIABETES CARE, INC. 11075 ROSELLE STREET SAN DIEGO CA 92121 0 1 0 0 EVP & Chief Admin. Officer Common Stock 2020-08-28 4 M 0 7522 18.86 A 13778 D Common Stock 2020-08-28 4 S 0 7522 114 D 6256 D Common Stock 2020-08-31 4 M 0 6548 18.86 A 12804 D Common Stock 2020-08-31 4 S 0 6548 114 D 6256 D Common Stock 2020-09-01 4 M 0 5930 18.86 A 12186 D Common Stock 2020-09-01 4 S 0 5930 114 D 6256 D Stock Option 18.86 2020-08-28 4 M 0 7522 0 D Common Stock 7522.0 72478 D Stock Option 18.86 2020-08-31 4 M 0 6548 0 D Common Stock 6548.0 65930 D Stock Option 18.86 2020-09-01 4 M 0 5930 0 D Common Stock 5930.0 60000 D Represents shares of common stock received upon exercise of a stock option award. The shares were sold, pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on May 19, 2020. The option vested as to fifty percent (50%) of the underlying shares on 06/14/2019, and the remaining shares vested in twelve (12) equal monthly installments thereafter. The expiration date for these options is 10 years from the date of grant. s/ David B. Berger, Attorney-in-Fact for Susan M. Morrison 2020-09-01